Home › DHA Speciality › Specialist Dermatology (DER5421)

Master Specialist Dermatology (DER5421)
for DHA Speciality

Access 289+ high-yield questions tailored for the 2026 syllabus. Includes AI-powered explanations and performance tracking.

Start Free Practice View Full Syllabus
HIGH YIELD NOTES Updated June 2026 · ~5 min read

Core Concepts

Dermatology involves the study of skin, hair, and nails. Key to diagnosis is understanding primary and secondary lesions, their morphology, configuration, and distribution. Primary lesions include macule, papule, plaque, nodule, vesicle, bulla, pustule, wheal. Secondary lesions result from primary lesion evolution or external factors, e.g., scale, crust, erosion, ulcer, fissure, atrophy, lichenification, scar. A strong grasp of skin anatomy (epidermis, dermis, subcutis) and basic pathophysiology (inflammation, infection, neoplasia, autoimmune processes) is crucial.

Clinical Presentation

  • Inflammatory Dermatoses:
    • Psoriasis: Chronic, immune-mediated. Erythematous plaques with silvery scales, well-demarcated, extensor surfaces (elbows, knees), scalp, nails. Auspitz sign, Koebner phenomenon. Types: chronic plaque, guttate, inverse, pustular, erythrodermic.
    • Atopic Dermatitis (Eczema): Pruritic, chronic inflammatory skin condition. Erythema, papules, vesicles, oozing, crusting in acute phases; lichenification in chronic. Flexural areas in adults, face/extensors in infants. Often personal/family history of atopy.
    • Contact Dermatitis: Acute or chronic inflammation from irritant exposure or allergic sensitization. Well-demarcated erythema, vesicles, bullae, pruritus, in exposed areas.
    • Lichen Planus: "6 Ps" - Pruritic, Polygonal, Planar, Purple, Papules, Plaques. Wickham's striae (oral mucosa), can affect hair (scarring alopecia) and nails.
    • Urticaria (Hives): Transient (usually <24h), pruritic, erythematous, edematous wheals. May be acute or chronic, associated with angioedema.
  • Infections:
    • Bacterial: Impetigo (honey-crusted erosions), Cellulitis (erythema, warmth, tenderness, poorly demarcated), Erysipelas (sharply demarcated, raised erythema). Folliculitis, furuncles, carbuncles.
    • Fungal (Tinea): Annular, scaly, pruritic plaques with central clearing (tinea corporis). Specific forms: tinea pedis, cruris, unguium, capitis. Candida presents with erythematous plaques, satellite papules/pustules in intertriginous areas.
    • Viral: Herpes Simplex (grouped vesicles on an erythematous base), Varicella/Zoster (dermatomal distribution of vesicles/crusts), Warts (verrucous papules, HPV), Molluscum Contagiosum (umbilicated papules).
  • Autoimmune/Blistering:
    • Pemphigus Vulgaris: Flaccid bullae, erosions, positive Nikolsky sign, often oral involvement. Intraepidermal blistering.
    • Bullous Pemphigoid: Tense bullae on erythematous or normal skin, negative Nikolsky sign, often elderly patients. Subepidermal blistering.
    • Cutaneous Lupus Erythematosus: Malar rash ("butterfly rash"), discoid lesions (atrophic, scarred plaques with follicular plugging, scarring alopecia), photosensitivity.
  • Neoplasms:
    • Basal Cell Carcinoma (BCC): Pearly papule/nodule with telangiectasias, rolled border, central ulceration. Most common skin cancer, rarely metastasizes.
    • Squamous Cell Carcinoma (SCC): Erythematous, scaly, crusted nodule or plaque, often ulcerated. Sun-exposed areas. Can metastasize. Keratoacanthoma is a variant.
    • Melanoma: High-risk. ABCDEs: Asymmetry, Border irregularity, Color variation, Diameter (>6mm), Evolving (change in size, shape, color, symptoms). Types: superficial spreading, nodular, lentigo maligna, acral lentiginous.
  • Other Common: Acne Vulgaris, Rosacea, Seborrheic Dermatitis.

Diagnosis (Gold Standard)

Often clinical assessment is sufficient for many common conditions. However, definitive diagnosis for complex, atypical, or neoplastic lesions relies on:

  • Biopsy (Histopathology): Punch, shave, or excisional biopsy for suspected neoplasms, blistering diseases, chronic inflammatory conditions, and any atypical or non-responsive dermatosis. Essential for defining diagnosis and guiding management.
  • Direct Immunofluorescence (DIF): Perilesional skin biopsy for autoimmune blistering diseases (pemphigus, pemphigoid) and connective tissue diseases (lupus) to detect antibody deposition.
  • Microbiological Tests:
    • KOH prep: Fungal elements for tinea/candida.
    • Tzank smear: Multinucleated giant cells for Herpesviridae infections.
    • Bacterial culture: For suspected bacterial infections.
  • Patch Testing: Gold standard for diagnosing allergic contact dermatitis.
  • Dermatoscopy: In-vivo examination of skin lesions, especially for pigmented lesions and early melanoma detection.
  • Serology: Autoantibodies (ANA, anti-dsDNA, anti-Ro/La) for connective tissue diseases; specific autoantibodies for blistering diseases.

Management (First Line)

Management strategies depend heavily on the specific diagnosis and severity:

  • Topical Corticosteroids: Mainstay for most inflammatory dermatoses (psoriasis, eczema, lichen planus). Potency varies based on site and severity.
  • Emollients/Moisturizers: Essential for barrier repair in dry skin conditions like eczema, psoriasis, xerosis.
  • Antihistamines: For symptomatic relief of pruritus (e.g., urticaria, eczema).
  • Phototherapy (UVB/UVA): For extensive psoriasis, severe eczema, vitiligo, CTCL.
  • Systemic Agents:
    • Immunosuppressants: Methotrexate, cyclosporine, azathioprine, mycophenolate for severe psoriasis, eczema, autoimmune blistering diseases, CTDs.
    • Biologics: For severe, recalcitrant psoriasis, atopic dermatitis, urticaria (e.g., TNF-α inhibitors, IL-17/23 inhibitors, IL-4/13 inhibitors).
    • Systemic Corticosteroids: For acute severe inflammatory conditions, blistering diseases, severe drug reactions (short-term).
  • Anti-infectives: Appropriate topical/oral antifungals, antivirals (acyclovir), antibiotics based on culture/susceptibility.
  • Surgery: Excisional biopsy for skin cancers (BCC, SCC, melanoma). Mohs micrographic surgery for high-risk BCC/SCC in cosmetically sensitive areas. Cryotherapy, electrodessication and curettage for benign lesions and some superficial cancers.
  • Acne: Topical retinoids, benzoyl peroxide, topical/oral antibiotics, oral isotretinoin for severe nodulocystic acne.

Exam Red Flags

  • Life-Threatening Conditions: Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), Erythroderma (any cause), Generalized Pustular Psoriasis, Necrotizing Fasciitis, widespread blistering diseases. Immediate recognition and management are critical.
  • Suspected Malignancy: Any rapidly growing, changing, bleeding, or non-healing lesion, especially those fitting the ABCDE criteria for melanoma. New or changing nodules/plaques in sun-exposed areas (BCC/SCC).
  • Immunocompromised Patients: Atypical presentations, rapid progression of infections (e.g., fungal, viral), or opportunistic infections (Kaposi's sarcoma).
  • Systemic Associations: Skin manifestations as a sign of underlying systemic disease (e.g., vasculitis, dermatomyositis, SLE, internal malignancy, inflammatory bowel disease).
  • Drug Reactions: Sudden onset, generalized, pruritic rashes (exanthematous, urticarial) following new medication, or severe blistering/desquamating reactions (SJS/TEN).
  • Child Abuse: Suspicious patterns of bruising, burns, or lesions inconsistent with history.
  • Severe Pain: Out of proportion to skin findings (e.g., Necrotizing Fasciitis, Herpes Zoster prior to eruption).

Sample Practice Questions

Question 1 FULLY WORKED EXAMPLE

A 34-year-old woman with moderate plaque psoriasis has been applying clobetasol propionate 0.05% ointment twice daily to her forearms and trunk for 11 weeks. She now reports new-onset burning and erythema in the treated areas, with several small pustules on the flexural surfaces. She is afebrile, and potassium hydroxide microscopy of a pustule roof is negative for fungal elements. What is the most appropriate next step in management?

A) Continue clobetasol propionate 0.05% ointment and add oral flucloxacillin
B) Switch to calcipotriol/betamethasone gel and reassess in 4 weeks
C) Stop clobetasol propionate and start a mid-potency topical corticosteroid with a tapering schedule ✓ Correct
D) Start oral prednisolone 30 mg daily for 2 weeks
Explanation:
The deciding finding is the 11-week duration of superpotent topical corticosteroid use with new burning, erythema, and pustules on flexural skin, which indicates topical steroid withdrawal or incipient atrophy rather than infection (KOH negative). The best action is to stop the superpotent steroid and transition to a mid-potency agent with tapering to avoid a rebound flare while allowing skin recovery. Continuing clobetasol (A) risks worsening atrophy and does not address the withdrawal reaction; antibiotics are unnecessary given the negative KOH and absence of fever. Calcipotriol/betamethasone (B) still contains a potent steroid and does not address the withdrawal. Oral prednisolone (D) is not indicated for localized steroid-induced skin changes and risks systemic adverse effects.
References: NICE Clinical Knowledge Summaries: Psoriasis - topical treatments and corticosteroid withdrawal
Question 2 TRY IT — TAP AN ANSWER

A 58-year-old man with type 2 diabetes and chronic kidney disease (eGFR 28 mL/min/1.73 m?) has severe nodulocystic acne. He has been on oral isotretinoin 40 mg daily for 6 weeks and now presents with widespread xerosis, cheilitis, and a new painful crusted lesion on his forearm. His fasting triglycerides are 4.8 mmol/L (reference

A) Continue isotretinoin at the same dose and add a topical emollient
B) Stop isotretinoin immediately and start oral prednisolone
C) Reduce isotretinoin dose and recheck lipids in 4 weeks
D) Stop isotretinoin, start oral doxycycline, and reassess after lipid normalization
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 3 TRY IT — TAP AN ANSWER

A 26-year-old woman with moderate acne has been using topical adapalene 0.1% gel nightly for 8 weeks. She now presents with a 3-day history of severe facial erythema, burning, and desquamation. She is 10 weeks pregnant. She has no fever or systemic symptoms. What is the most appropriate next step?

A) Continue adapalene and add a topical antibiotic
B) Stop adapalene and start topical benzoyl peroxide 5%
C) Stop adapalene and start oral isotretinoin
D) Stop adapalene and start oral tetracycline
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 4 TRY IT — TAP AN ANSWER

A 45-year-old man with chronic plaque psoriasis has been treated with methotrexate 15 mg weekly for 6 months. He presents with a 1-week history of painful oral ulcers, fatigue, and a new erythematous rash on his trunk. His full blood count shows a white cell count of 2.1 x 109/L (reference 4.0-11.0), and his liver enzymes are mildly elevated. He reports no alcohol use. What is the most appropriate immediate action?

A) Continue methotrexate and add folic acid 5 mg daily
B) Stop methotrexate and start folinic acid rescue
C) Reduce methotrexate dose to 10 mg weekly
D) Stop methotrexate and start oral prednisolone 40 mg daily
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.
Question 5 TRY IT — TAP AN ANSWER

A 62-year-old woman with severe bullous pemphigoid has been started on oral prednisolone 40 mg daily. After 3 weeks, she presents with a 2-day history of melaena and dizziness. Her blood pressure is 98/60 mmHg, and her haemoglobin is 78 g/L (reference 120-150 g/L). She is on no anticoagulants. What is the most appropriate next step?

A) Continue prednisolone and add an oral proton pump inhibitor
B) Stop prednisolone immediately and start topical clobetasol propionate
C) Reduce prednisolone to 20 mg daily and transfuse packed red cells
D) Stop prednisolone, resuscitate, and start an alternative immunosuppressant such as doxycycline or rituximab
💡 Pick an answer above to see if you're right — the full explanation unlocks instantly.

Want 289+ more Specialist Dermatology (DER5421) questions?

Start Free — No Card Needed

DHA Speciality

  • ✓ 289+ Specialist Dermatology (DER5421) Questions
  • ✓ AI Tutor Assistance
  • ✓ Detailed Explanations
  • ✓ Performance Analytics
Get Full Access

Specialist Dermatology (DER5421) Questions for DHA Speciality — FAQ

How many Specialist Dermatology (DER5421) questions does MedLumen have for DHA Speciality?

MedLumen currently has 289+ Specialist Dermatology (DER5421) practice questions for DHA Speciality, each with a detailed explanation so you understand the reasoning behind every answer.

Are the Specialist Dermatology (DER5421) questions updated for the 2026 DHA Speciality syllabus?

Yes. Our Specialist Dermatology (DER5421) questions are mapped to the latest DHA Speciality blueprint and reviewed regularly so they stay aligned with the current 2026 syllabus.

Can I practise Specialist Dermatology (DER5421) questions for free?

You can preview sample Specialist Dermatology (DER5421) questions for free. A MedLumen subscription unlocks all 289+ Specialist Dermatology (DER5421) questions, full answer explanations, and performance analytics for DHA Speciality.

How should I revise Specialist Dermatology (DER5421) for DHA Speciality?

Practise Specialist Dermatology (DER5421) questions in timed blocks, read the explanation for every answer (right or wrong), and use MedLumen's analytics to revisit your weak areas until your accuracy is consistently high.

Prepare for DHA Speciality with MedLumen →